Widschwendter M - Search Results

1

Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.

Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman LD, Berchuck A, Pearce CL, Laird PW. Campan M, et al. Among authors: widschwendter m. PLoS One. 2011;6(12):e28141. doi: 10.1371/journal.pone.0028141. Epub 2011 Dec 7. PLoS One. 2011. PMID: 22163280 Free PMC article.

2

Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.

Widschwendter M, Daxenbichler G, Dapunt O, Marth C. Widschwendter M, et al. Cancer Res. 1995 May 15;55(10):2135-9. Cancer Res. 1995. PMID: 7743514

3

[Interaction of interferon with retinoic acid].

Widschwendter M, Daxenbichler G, Marth C, Dapunt O. Widschwendter M, et al. Gynakol Geburtshilfliche Rundsch. 1994;34(3):168-70. doi: 10.1159/000272362. Gynakol Geburtshilfliche Rundsch. 1994. PMID: 7987085 German.

4

Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells.

Marth C, Widschwendter M, Daxenbichler G. Marth C, et al. Among authors: widschwendter m. J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):123-6. doi: 10.1016/0960-0760(93)90065-5. J Steroid Biochem Mol Biol. 1993. PMID: 8274426

5

Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.

Daxenbichler G, Widschwendter M, Marth C. Daxenbichler G, et al. Among authors: widschwendter m. Ann N Y Acad Sci. 1996 Apr 30;784:294-303. doi: 10.1111/j.1749-6632.1996.tb16244.x. Ann N Y Acad Sci. 1996. PMID: 8651578 No abstract available.

6

[Immunostimulating protein 90K in ovarian carcinoma].

Zeimet AG, Marth C, Fuchs D, Herold M, Widschwendter M, Daxenbichler G, Iacobelli S, Dapunt O. Zeimet AG, et al. Among authors: widschwendter m. Gynakol Geburtshilfliche Rundsch. 1996;36(1):44-5. doi: 10.1159/000272613. Gynakol Geburtshilfliche Rundsch. 1996. PMID: 8737525 Free article. German.

7

Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.

Marth C, Zeimet AG, Widschwendter M, Ludescher C, Kaern J, Tropé C, Gastl G, Daxenbichler G, Dapunt O. Marth C, et al. Among authors: widschwendter m. Cancer Res. 1997 Sep 1;57(17):3818-22. Cancer Res. 1997. PMID: 9288793

8

Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.

Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG. Widschwendter M, et al. Among authors: widschwendter a. Cancer Res. 1997 Oct 1;57(19):4158-61. Cancer Res. 1997. PMID: 9331065

9

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.

Zeimet AG, Widschwendter M, Uhl-Steidl M, Müller-Holzner E, Daxenbichler G, Marth C, Dapunt O. Zeimet AG, et al. Among authors: widschwendter m. Br J Cancer. 1997;76(12):1646-51. doi: 10.1038/bjc.1997.611. Br J Cancer. 1997. PMID: 9413956 Free PMC article.

10

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.

Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Müller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C. Zeimet AG, et al. Among authors: widschwendter m. J Clin Oncol. 1998 May;16(5):1861-8. doi: 10.1200/JCO.1998.16.5.1861. J Clin Oncol. 1998. PMID: 9586902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page